BMPR-1A

BMPR-1A Molekülinformation

Englischer Name	Bone morphogenetic protein receptor type-1A	Anzahl der inverkehr gebrachten Arzneimittel	2
Anzahl der klinischen Arzneimittel	2	Target-Alias	Bone Morphogenetic Protein Receptor Type 1A，EC 2.7.11，Activin receptor-like kinase 3，Bone morphogenetic protein receptor type-1A，ALK3，BMPR1A，Bone Morphogenetic Protein Receptor， Type IA，Serine/Threonine-Protein Kinase Receptor R5，ACVRLK3，BMPR-1A，SKR5，Activin A Receptor， Type II-Like Kinase 3，CD292 Antigen，EC 2.7.11.30，10q23del，CD292，BMP type-1A receptor，ALK-3，EC:2.7.11.30
Höchste Forschungs- und Entwicklungsphase	Approved

Englischer Name	Bone morphogenetic protein receptor type-1A
Target-Alias	Bone Morphogenetic Protein Receptor Type 1A，EC 2.7.11，Activin receptor-like kinase 3，Bone morphogenetic protein receptor type-1A，ALK3，BMPR1A，Bone Morphogenetic Protein Receptor， Type IA，Serine/Threonine-Protein Kinase Receptor R5，ACVRLK3，BMPR-1A，SKR5，Activin A Receptor， Type II-Like Kinase 3，CD292 Antigen，EC 2.7.11.30，10q23del，CD292，BMP type-1A receptor，ALK-3，EC:2.7.11.30
Anzahl der inverkehr gebrachten Arzneimittel	2
Anzahl der klinischen Arzneimittel	2
Höchste Forschungs- und Entwicklungsphase	Approved

BMPR-1A Produktliste

Attribut
Protein (2)
Produktbibliothek
Online (2)
Spezies
Human (2)
Etikett
Fc Tag (1)His Tag (1)
Marker
Unconjugated (2)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
AL3-H5259	Human	HEK293	Human BMPR-1A / ALK-3 Protein, Fc Tag				In den Warenkorb legen
AL3-H52H9	Human	HEK293	Human BMPR-1A / ALK-3 Protein, His Tag (MALS verified)				In den Warenkorb legen

Gesamtmenge2

BMPR-1A Molekülhintergrund

The bone morphogenetic protein receptor, type IA is also known as BMPR1A or ALK3 is a protein which in humans is encoded by the BMPR1A gene. BMPR1A has also been designated as CD292 (cluster of differentiation 290). The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A (this protein) and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. Alk3-mediated BMP signaling in AV endocardial/mesenchymal cells plays a central role during cushion morphogenesis.

BMPR-1A Molekülalias

BMPR-1A,ALK-3,ACVRLK3,CD292,SKR5

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Recombinant Human Bone Morphogenetic Protein-2（University Of Baghdad）		Phase 1 Clinical	University Of Baghdad	Diabetes Mellitus; Hematologic Diseases; Hypertension	Details
Recombinant human bone morphogenetic protein 4 (Stemgen)	HS-214; hrBMP4	Phase 1 Clinical	Stemgen	Asthma; Bronchiolitis Obliterans; Glioblastoma; Lung Diseases; Rejection of lung transplantation	Details

Inverkehr gebrachte Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Frühestes Markenname	Frühestes Genehmigungsland	Früheste Indikation	Früheste Genehmigungsgesellschaft	Früheste Genehmigungsdatum	Indikationen	Klinische Studie
Dibotermin alfa	YM-484; rhBMP-2/CPM	Approved	Medtronic	Inductos	EU	Tibial Fractures	Medtronic Biopharma Bv	2002-09-09	Fractures, Bone; Osteoarthritis; Osteoarthritis, Spine; Radius Fractures; Tibial Fractures; Tooth Injuries	Details
DWP-431	DWP-431; rhBMP-2	Approved	Daewoong Pharmaceutical Co Ltd	Novosis, Novosis-Dental	South Korea	Alveolar Bone Loss	Daewoong Pharmaceutical Co Ltd	2013-01-01	Alveolar Bone Loss; Intervertebral Disc Degeneration	Details